Showing results (301-310 of 399) with videos related to
Sort By:
Pageof 40
Nature Medicine|December 7, 2021
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trialJason Gotlib, Andreas Reiter, Deepti H Radia, et al.Blood Advances|October 6, 2021
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and activeJacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.Science Translational Medicine|December 9, 2016
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissionsJacalyn Rosenblatt, Richard M Stone, Lynne Uhl, et al.Cancer Cell|June 5, 2003
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative diseaseJan Cools, Elizabeth H Stover, Christina L Boulton, et al.Blood Neoplasia|March 20, 2026
Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogeneticsLuis E Aguirre, Jan Philipp Bewersdorf, Yiwen Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemiaAkinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.The New England Journal of Medicine|March 28, 2003
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndromeJan Cools, Daniel J DeAngelo, Jason Gotlib, et al.Developmental Cell|August 27, 2025
Loss of NOTCH2 creates a TRIM28-dependent vulnerability in small cell lung cancerDeli Hong, Ying Lyu, Richa Nayak, et al.Cancer Discovery|May 7, 2020
Inactivation of Fbxw7 Impairs dsRNA Sensing and Confers Resistance to PD-1 BlockadeCécile Gstalder, David Liu, Diana Miao, et al.Leukemia|July 16, 2026
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final resultsJorge E Cortes, Delphine Rea, Michael J Mauro, et al.Pageof 40